RECURSION PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2020 to 2023.
  • Recursion Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $124M, a 13% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $459M, a 27.8% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $395M, a 38.2% increase from 2022.
  • Recursion Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $286M, a 48% increase from 2021.
  • Recursion Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $193M, a 118% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $395M +$109M +38.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $286M +$92.6M +48% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $193M +$104M +118% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $88.6M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.